Funding round
Enveda Series C
Enveda, which works in drug discovery and development in Boulder, raised $130M in a Series C round announced on 21 Nov 2024, led by Kinnevik and FPV Ventures. 11 firms took part. It is Enveda's fourth venture round on record; the one before was a Series B in Dec 2022.
$130M
Amount raised
Not disclosed
Post-money valuation
11
Investors
2 leads
Valuation
What this round says about the price
Enveda did not disclose a valuation in this round. It came 23 months after Enveda's Series B. It is 18% of the $715M Enveda has raised in the venture rounds on record. Enveda raised again 10 months later: a Series D round of $150M in Sep 2025. Its next priced round, a Series E in Sep 2026, valued it at $2.00B.
Enveda's funding rounds
Enveda has 6 venture rounds on record. This one is highlighted.
- Seed 27 Dec 2020, led by True Ventures $4.9M
- Series A 22 Jun 2021, led by Lux Capital $51M
- Series B 21 Dec 2022, led by Dimension $68M
- Series C this round 21 Nov 2024, led by Kinnevik and FPV Ventures $130M
- Series D 4 Sep 2025, led by Premji Invest $150M
- Series E 23 Sep 2026, led by Catalio Capital Management $311M$2.00B post-money
Investors
Who put money in
Kinnevik and FPV Ventures led the round with 9 other firms.
Lead investors
- Kinnevik backs 55 venture-backed companies new investor
- backs 39 venture-backed companies new investor
Also in the round
- Baillie Gifford new investor
- Premji Invest backs 50 venture-backed companies new investor
- Lingotto Innovation new investor
- Lux Capital backs 194 venture-backed companies new investor
- backs 24 venture-backed companies new investor
- backs 158 venture-backed companies new investor
- Cresset Partners new investor
- The Nature Conservancy new investor
- Henry R. Kravis new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
35 Series C rounds in Biotechnology within a year either side disclosed an amount; the median was $55M, and this round was 2.4 times the median. The closest in time, other companies' Series C rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 26 Nov 2024 | $53M | not disclosed | Frazier Life Sciences |
| Pathos Biotechnology | 29 Oct 2024 | $62M | $600M | New Enterprise Associates |
| Biotechnology | 24 Dec 2024 | $15M | not disclosed | not named |
| Arsenal Bio Biotechnology | 4 Sep 2024 | $325M | not disclosed | ARCH Venture Partners and NVentures |
| Biotechnology | 7 Jan 2025 | $208M | not disclosed | Omega Funds and TCG Crossover |
| Colossal Biotechnology | 17 Jan 2025 | $200M | $10.20B | TWG Global |
| Biotechnology | 15 Jan 2025 | $92M | not disclosed | Nextech Invest |
| Biotechnology | 9 Jan 2025 | $55M | not disclosed | Cormorant Asset Management and Forbion |
Sources
Where this comes from
Reported by 3 sources.
Questions
Frequently asked
How much did Enveda raise in its Series C round?
Enveda raised $130M in its Series C round, announced in Nov 2024.
Who led Enveda's Series C round?
Kinnevik and FPV Ventures led it, with Baillie Gifford, Premji Invest, Lingotto Innovation, Lux Capital and Dimension and 4 more.
What was Enveda's valuation at the Series C round?
It was not disclosed.
How does it compare with other Series C rounds in Biotechnology?
35 Series C rounds in Biotechnology within a year either side disclosed an amount; the median was $55M, and this round was 2.4 times the median.
Did Enveda raise again after this round?
Yes: a Series D round in Sep 2025 of $150M.